US ranitidine litigation unlikely to have impact on Indian pharma: Analysts
Sun Pharmaceuticals, Dr Reddy''s Laboratories, Perrigo and Teva have agreed to a combined settlement of $5 mn with cancer patient Joseph Bayer
US ranitidine litigation unlikely to have impact on Indian pharma: Analysts
Sun Pharmaceuticals, Dr Reddy''s Laboratories, Perrigo and Teva have agreed to a combined settlement of $5 mn with cancer patient Joseph Bayer